Results 241 to 250 of about 167,619 (306)

Targeting the Urokinase-Type Plasminogen Activator Receptor (uPAR) in Human Diseases With a View to Non-invasive Imaging and Therapeutic Intervention. [PDF]

Front Cell Dev Biol, 2021
Leth JM, Ploug M.
europepmc   +1 more source

Ligand Binding to Macrophage Scavenger Receptor-A Induces Urokinase-type Plasminogen Activator Expression by a Protein Kinase-dependent Signaling Pathway [PDF]

, 1998
Hsien‐Yeh Hsu, David P. Hajjar, Korsa Khan, Domenick J. Falcone   +3 more
openalex   +1 more source

Soluble Urokinase-Type Plasminogen Activator Receptor, Changes of 24-Hour Blood Pressure, and Progression of Chronic Kidney Disease. [PDF]

J Am Heart Assoc, 2021
Jhee JH, Nam BY, Lee CJ, Park JT, Han SH, Kang SW, Park S, Yoo TH.   +7 more
europepmc   +1 more source

Glycosylation Profile of a Recombinant Urokinase-type Plasminogen Activator Receptor Expressed in Chinese Hamster Ovary Cells [PDF]

, 1998
Michael Ploug, Henrik Rahbek-Nielsen, Per F. Nielsen, Peter Roepstorff, Keld Danø   +4 more
openalex   +1 more source

Urokinase-type plasminogen activator promotes synaptic repair in the ischemic brain

Neural Regeneration Research, 2018
Ariel Diaz, Manuel Yepes
doaj   +1 more source

Efficacy of Rituximab in Treatment-Resistant Focal Segmental Glomerulosclerosis With Elevated Soluble Urokinase-Type Plasminogen Activator Receptor and Activation of Podocyte β3 Integrin. [PDF]

Kidney Int Rep, 2022
Hladunewich MA, Cattran D, Sethi SM, Hayek SS, Li J, Wei C, Mullin SI, Reich HN, Reiser J, Fervenza FC.   +9 more
europepmc   +1 more source

Urokinase-type plasminogen activator inhibits α4β1 integrin-mediated T lymphocyte adhesion to fibronectin independently of its catalytic activity [PDF]

, 1999
Philippe Olivier, Grégory Bieler, Kai M. Müller, Dan Hauzenberger, Curzio Rüegg   +4 more
openalex   +1 more source

Diagnostic value of soluble urokinase-type plasminogen activator receptor in patients with acute coronary syndrome: A systematic review and meta-analysis. [PDF]

Cardiol J
Pruc M, Jannasz I, Swieczkowski D, Procyk G, Gasecka A, Rafique Z, Chirico F, Bragazzi NL, Jaguszewski MJ, Wysocki J, Szarpak L.   +10 more
europepmc   +1 more source

Soluble urokinase-type plasminogen activator receptor (suPAR) is a risk indicator for eGFR loss in kidney transplant recipients. [PDF]

Sci Rep, 2021
Jehn U, Schütte-Nütgen K, Henke U, Pavenstädt H, Suwelack B, Reuter S.   +5 more
europepmc   +1 more source

Expression of Urokinase-type Plasminogen Activator(uRA), Plasminogen Activator Inhibitor-1(PAI-1) and nm23 protein, as Prognostic Factors in Epithelial Ovarian Cancer [PDF]

, 1998
Kyung Tai Kim, Ho Sang Seo, Ki Heon Lee, Young Jin Moon, Sam Hyun Cho, Hyung Moon, Wan Sub Kim, Moon Hyang Park, Youn Hwang   +8 more
openalex   +1 more source